Vitalhub (TSE:VHI) Trading Down 2.6% – Time to Sell?

Vitalhub Corp. (TSE:VHI) traded down 2.6% during trading on Thursday . The stock traded as low as C$7.20 and last traded at C$7.23. 187,463 shares changed hands during mid-day trading, a decline of 48% from the average session volume of 357,574 shares. The stock had previously closed at C$7.42.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. National Bank Financial lowered their price objective on shares of Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating for the company in a research report on Wednesday, May 27th. Raymond James Financial lowered their price objective on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating for the company in a research report on Tuesday, March 24th. One equities research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of C$13.14.

Vitalhub Price Performance

The stock has a market cap of C$435.86 million, a price-to-earnings ratio of 57.42, a P/E/G ratio of 1.18 and a beta of 0.91. The business’s fifty day simple moving average is C$7.21 and its 200 day simple moving average is C$7.77.

Vitalhub (TSE:VHI) last released its quarterly earnings data on Thursday, May 7th. The company reported C$0.04 EPS for the quarter. Vitalhub had a net margin of 6.13% and a return on equity of 2.98%. The firm had revenue of C$31.91 million during the quarter. As a group, equities analysts forecast that Vitalhub Corp. will post 0.2296467 EPS for the current fiscal year.

About Vitalhub

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.